Viewing data from:

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

ANDA

BRIMONIDINE TARTRATE; TIMOLOL MALEATE | A091087 | SANDOZ INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: COMBIGAN(TE code: AB)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Allergan Sales, LLC v. Sandoz, Inc. 2:2015cv00347 4 patentsANDA 091087brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%	E.D. Tex.	2015-03-09	Terminated 2016-12-30	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 26, 2022	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.2%;EQ 0.5% BASE

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Apr 4, 2022

No patent or exclusivity listings for this strength.